Policy and Medicine Compliance Update April 2023 Issue Features: DOJ’s updated Evaluation of Compliance Program guidance, and End of COVID-19 Health Emergency What Does that Mean for Compliance Read more
Policy and Medicine March 2022 Issue Features FDA Exclusivity, Baby Powder, and FCA Case Dismissal Read more
State Policy: New Jersey Senate Committee Passes Conflict of Interest Restrictions on Hospitals Read more